Personal tools

MCL coexpression mm9:172: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.308698599998816,0.631785067423811,0.60863887609606,0.495641816735151,0.786458247205087,0.899930980762698,0.926398336935497,0.785130058217951,0.725937564092145,0.298276347649456,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0805006992779881,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0388749848471105,0.0269518943326477,0.0242538736058389,0,0.0476191773904887,0,0,0.0596387295197733,0,0.0709519923534245,0.092873634605593,0.0589368614163519,0.0390607415003592,0.0352754493378881,0.0729583017401753,0,0.0553034373508932,0,0.0486884105045233,0.0780974029773103,0,0,0,0,0,0,0,0,0
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.308698599998816,0.631785067423811,0.60863887609606,0.495641816735151,0.786458247205087,0.899930980762698,0.926398336935497,0.785130058217951,0.725937564092145,0.298276347649456,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0805006992779881,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0388749848471105,0.0269518943326477,0.0242538736058389,0,0.0476191773904887,0,0,0.0596387295197733,0,0.0709519923534245,0.092873634605593,0.0589368614163519,0.0390607415003592,0.0352754493378881,0.0729583017401753,0,0.0553034373508932,0,0.0486884105045233,0.0780974029773103,0,0,0,0,0,0,0,0,0
|gostat_on_MCL_coexpression=GO:0004133;glycogen debranching enzyme activity;0.00777954308880732;77559!GO:0016519;gastric inhibitory peptide receptor activity;0.00777954308880732;381853!GO:0042805;actinin binding;0.0103718716591627;380928!GO:0001636;corticotrophin-releasing factor gastric inhibitory peptide-like receptor activity;0.0116673966699664;381853!
|gostat_on_MCL_coexpression=GO:0004133;glycogen debranching enzyme activity;0.00777954308880732;77559!GO:0016519;gastric inhibitory peptide receptor activity;0.00777954308880732;381853!GO:0042805;actinin binding;0.0103718716591627;380928!GO:0001636;corticotrophin-releasing factor gastric inhibitory peptide-like receptor activity;0.0116673966699664;381853!
|ontology_enrichment_celltype=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0007100!6.40e-20!18;UBERON:0000948!6.40e-20!18;UBERON:0005498!6.40e-20!18;UBERON:0004140!6.40e-20!18;UBERON:0009881!6.40e-20!18;UBERON:0004141!6.40e-20!18;UBERON:0003084!6.40e-20!18;UBERON:0007005!6.40e-20!18;UBERON:0004139!6.40e-20!18;UBERON:0004291!6.40e-20!18;UBERON:0004535!3.34e-15!23;UBERON:0001009!3.34e-15!23;UBERON:0004872!4.72e-10!33;UBERON:0003103!6.92e-09!43
}}
}}

Revision as of 17:20, 11 October 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:30557698..30557717,-p@chr10:30557698..30557717
-
Mm9::chr10:63117936..63117942,+p@chr10:63117936..63117942
+
Mm9::chr11:88702790..88702805,-p5@Akap1
Mm9::chr13:45825796..45825807,+p@chr13:45825796..45825807
+
Mm9::chr14:102283344..102283353,+p26@Lmo7
Mm9::chr14:55592627..55592655,-p@chr14:55592627..55592655
-
Mm9::chr14:55592659..55592677,-p@chr14:55592659..55592677
-
Mm9::chr14:55592682..55592691,-p@chr14:55592682..55592691
-
Mm9::chr14:55592874..55592887,-p@chr14:55592874..55592887
-
Mm9::chr14:55593556..55593569,-p@chr14:55593556..55593569
-
Mm9::chr14:55593594..55593605,-p@chr14:55593594..55593605
-
Mm9::chr14:55594807..55594837,+p@chr14:55594807..55594837
+
Mm9::chr14:55594816..55594843,-p1@Mir208b
Mm9::chr14:55594906..55594919,-p2@Mir208b
Mm9::chr14:55597498..55597518,-p@chr14:55597498..55597518
-
Mm9::chr14:55601007..55601013,+p@chr14:55601007..55601013
+
Mm9::chr14:55602120..55602145,-p@chr14:55602120..55602145
-
Mm9::chr14:55602153..55602164,-p@chr14:55602153..55602164
-
Mm9::chr14:55602185..55602196,-p@chr14:55602185..55602196
-
Mm9::chr14:55602212..55602241,-p@chr14:55602212..55602241
-
Mm9::chr14:55602248..55602254,-p@chr14:55602248..55602254
-
Mm9::chr14:55602387..55602410,+p@chr14:55602387..55602410
+
Mm9::chr14:55602438..55602483,-p@chr14:55602438..55602483
-
Mm9::chr14:55602607..55602628,-p@chr14:55602607..55602628
-
Mm9::chr14:55603569..55603586,-p@chr14:55603569..55603586
-
Mm9::chr14:55603590..55603599,-p@chr14:55603590..55603599
-
Mm9::chr14:55603637..55603654,-p@chr14:55603637..55603654
-
Mm9::chr14:55603961..55603979,-p@chr14:55603961..55603979
-
Mm9::chr14:55603984..55603995,-p@chr14:55603984..55603995
-
Mm9::chr14:55607937..55607949,-p@chr14:55607937..55607949
-
Mm9::chr14:55607964..55607977,-p@chr14:55607964..55607977
-
Mm9::chr14:55608204..55608213,-p@chr14:55608204..55608213
-
Mm9::chr14:55609205..55609219,-p@chr14:55609205..55609219
-
Mm9::chr14:55609568..55609585,+p@chr14:55609568..55609585
+
Mm9::chr14:55609790..55609804,-p@chr14:55609790..55609804
-
Mm9::chr14:55610436..55610483,-p@chr14:55610436..55610483
-
Mm9::chr14:55612172..55612191,-p@chr14:55612172..55612191
-
Mm9::chr14:55612194..55612219,-p@chr14:55612194..55612219
-
Mm9::chr14:55612222..55612258,-p@chr14:55612222..55612258
-
Mm9::chr14:55613118..55613152,-p@chr14:55613118..55613152
-
Mm9::chr16:38713541..38713552,-p13@Arhgap31
Mm9::chr17:12845507..12845518,-p@chr17:12845507..12845518
-
Mm9::chr17:12845536..12845545,-p@chr17:12845536..12845545
-
Mm9::chr17:12845605..12845619,-p@chr17:12845605..12845619
-
Mm9::chr17:81870622..81870634,-p@chr17:81870622..81870634
-
Mm9::chr17:81997612..81997620,-p@chr17:81997612..81997620
-
Mm9::chr17:82003607..82003626,-p@chr17:82003607..82003626
-
Mm9::chr17:82021802..82021805,-p@chr17:82021802..82021805
-
Mm9::chr17:82124931..82124935,-p@chr17:82124931..82124935
-
Mm9::chr17:82130225..82130232,-p@chr17:82130225..82130232
-
Mm9::chr17:82130245..82130263,-p@chr17:82130245..82130263
-
Mm9::chr17:82130855..82130867,-p@chr17:82130855..82130867
-
Mm9::chr17:82132312..82132315,-p@chr17:82132312..82132315
-
Mm9::chr1:137698276..137698287,+p@chr1:137698276..137698287
+
Mm9::chr2:35115173..35115177,+p@chr2:35115173..35115177
+
Mm9::chr3:116510798..116510807,-p14@Agl
Mm9::chr3:19579033..19579042,+p@chr3:19579033..19579042
+
Mm9::chr3:40486470..40486504,-p@chr3:40486470..40486504
-
Mm9::chr6:119165352..119165361,+p6@Dcp1b
Mm9::chr6:119165367..119165378,+p2@Dcp1b
Mm9::chr7:129190415..129190425,-p@chr7:129190415..129190425
-
Mm9::chr7:129190428..129190447,-p@chr7:129190428..129190447
-
Mm9::chr7:19751468..19751483,-p1@Gipr


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0004133glycogen debranching enzyme activity0.00777954308880732
GO:0016519gastric inhibitory peptide receptor activity0.00777954308880732
GO:0042805actinin binding0.0103718716591627
GO:0001636corticotrophin-releasing factor gastric inhibitory peptide-like receptor activity0.0116673966699664



Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:172&oldid=2153865"